Thomas J. Schuetz - Net Worth and Insider Trading
Thomas J. Schuetz Net Worth
The estimated net worth of Thomas J. Schuetz is at least $10 Million dollars as of 2024-04-26. Thomas J. Schuetz is the CHIEF EXECUTIVE OFFICER of Compass Therapeutics Inc and owns about 6,021,873 shares of Compass Therapeutics Inc (CMPX) stock worth over $9 Million. Thomas J. Schuetz is also the Director of Relypsa Inc and owns about 33,962 shares of Relypsa Inc (RLYP) stock worth over $1 Million. Details can be seen in Thomas J. Schuetz's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Thomas J. Schuetz has not made any transactions after 2023-03-10 and currently still holds the listed stock(s).
Transaction Summary of Thomas J. Schuetz
Thomas J. Schuetz Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Thomas J. Schuetz owns 1 companies in total, including Compass Therapeutics Inc (CMPX) .
Click here to see the complete history of Thomas J. Schuetz’s form 4 insider trades.
Insider Ownership Summary of Thomas J. Schuetz
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CMPX | Compass Therapeutics Inc | 2023-03-10 | director & Chief Executive Officer |
Thomas J. Schuetz Latest Holdings Summary
Thomas J. Schuetz currently owns a total of 2 stocks. Among these stocks, Thomas J. Schuetz owns 6,021,873 shares of Compass Therapeutics Inc (CMPX) as of March 10, 2023, with a value of $9 Million and a weighting of 89.13%. Thomas J. Schuetz also owns 33,962 shares of Relypsa Inc (RLYP) as of March 15, 2016, with a value of $1 Million and a weighting of 10.87%.
Latest Holdings of Thomas J. Schuetz
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CMPX | Compass Therapeutics Inc | 2023-03-10 | 6,021,873 | 1.48 | 8,912,372 |
| RLYP | Relypsa Inc | 2016-03-15 | 33,962 | 31.99 | 1,086,444 |
Holding Weightings of Thomas J. Schuetz
Thomas J. Schuetz Form 4 Trading Tracker
According to the SEC Form 4 filings, Thomas J. Schuetz has made a total of 21 transactions in Compass Therapeutics Inc (CMPX) over the past 5 years, including 21 buys and 0 sells. The most-recent trade in Compass Therapeutics Inc is the acquisition of 10,000 shares on March 10, 2023, which cost Thomas J. Schuetz around $33,700.
According to the SEC Form 4 filings, Thomas J. Schuetz has made a total of 0 transactions in Relypsa Inc (RLYP) over the past 5 years. The most-recent trade in Relypsa Inc is the acquisition of 30,000 shares on March 15, 2016, which cost Thomas J. Schuetz around $401,700.
Insider Trading History of Thomas J. Schuetz
- 1
Thomas J. Schuetz Trading Performance
GuruFocus tracks the stock performance after each of Thomas J. Schuetz's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Thomas J. Schuetz is 31.19%. GuruFocus also compares Thomas J. Schuetz's trading performance to market benchmark return within the same time period. The performance of stocks bought by Thomas J. Schuetz within 3 months outperforms 15 times out of 21 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Thomas J. Schuetz's insider trading performs compared to the benchmark.
Performance of Thomas J. Schuetz
Average Return
-3.84%
Outperforming Transactions
52%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 8.21 | 31.19 | 40.45 | -3.84 | ||
| Relative Return to S&P 500(%) | 10.24 | 29.79 | 36.97 | -16.79 |
Thomas J. Schuetz Ownership Network
Ownership Network List of Thomas J. Schuetz
Ownership Network Relation of Thomas J. Schuetz
Thomas J. Schuetz Owned Company Details
What does Compass Therapeutics Inc do?
Who are the key executives at Compass Therapeutics Inc?
Thomas J. Schuetz is the director & Chief Executive Officer of Compass Therapeutics Inc. Other key executives at Compass Therapeutics Inc include Chief Operating Officer Vered Bisker-leib , director & 10 percent owner Orbimed Advisors Llc , and director & 10 percent owner Carl L Gordon .
Compass Therapeutics Inc (CMPX) Insider Trades Summary
Over the past 18 months, Thomas J. Schuetz made 5 insider transaction in Compass Therapeutics Inc (CMPX) with a net purchase of 90,000. Other recent insider transactions involving Compass Therapeutics Inc (CMPX) include a net sale of 46,761 shares made by Vered Bisker-leib , a net purchase of 402,000 shares made by Carl L Gordon , and a net purchase of 402,000 shares made by Orbimed Advisors Llc .
In summary, during the past 3 months, insiders sold 0 shares of Compass Therapeutics Inc (CMPX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 46,761 shares of Compass Therapeutics Inc (CMPX) were sold and 894,000 shares were bought by its insiders, resulting in a net purchase of 847,239 shares.
Compass Therapeutics Inc (CMPX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Compass Therapeutics Inc Insider Transactions
Thomas J. Schuetz Mailing Address
Above is the net worth, insider trading, and ownership report for Thomas J. Schuetz. You might contact Thomas J. Schuetz via mailing address: C/o Relypsa, Inc., 700 Saginaw Dr., Redwood City Ca 94063.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
